These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

206 related items for PubMed ID: 26874511

  • 21. The effects of cytotoxic therapy in progressive IgA nephropathy.
    Shin JH, Lee JE, Park JH, Lim S, Jang HR, Kwon GY, Huh W, Jung SH, Kim YG, Oh HY, Kim DJ.
    Ann Med; 2016; 48(3):171-81. PubMed ID: 27031662
    [Abstract] [Full Text] [Related]

  • 22. Treatment with low-dose angiotensin-converting enzyme inhibitor (ACEI) plus angiotensin II receptor blocker (ARB) in pediatric patients with IgA nephropathy.
    Yang Y, Ohta K, Shimizu M, Nakai A, Kasahara Y, Yachie A, Koizumi S.
    Clin Nephrol; 2005 Jul; 64(1):35-40. PubMed ID: 16047643
    [Abstract] [Full Text] [Related]

  • 23. Antiproteinuric effects of angiotensin receptor blockers: telmisartan versus valsartan in hypertensive patients with type 2 diabetes mellitus and overt nephropathy.
    Galle J, Schwedhelm E, Pinnetti S, Böger RH, Wanner C, VIVALDI investigators.
    Nephrol Dial Transplant; 2008 Oct; 23(10):3174-83. PubMed ID: 18450829
    [Abstract] [Full Text] [Related]

  • 24. Thiazide diuretics enhance nocturnal blood pressure fall and reduce proteinuria in immunoglobulin A nephropathy treated with angiotensin II modulators.
    Uzu T, Harada T, Namba T, Yamamoto R, Takahara K, Yamauchi A, Kimura G.
    J Hypertens; 2005 Apr; 23(4):861-5. PubMed ID: 15775792
    [Abstract] [Full Text] [Related]

  • 25. Combined treatment with renin-angiotensin system blockers and polyunsaturated fatty acids in proteinuric IgA nephropathy: a randomized controlled trial.
    Ferraro PM, Ferraccioli GF, Gambaro G, Fulignati P, Costanzi S.
    Nephrol Dial Transplant; 2009 Jan; 24(1):156-60. PubMed ID: 18685141
    [Abstract] [Full Text] [Related]

  • 26. Urinary excretion of β2-microglobulin as a prognostic marker in immunoglobulin A nephropathy.
    Shin JR, Kim SM, Yoo JS, Park JY, Kim SK, Cho JH, Jeong KH, Lee TW, Ihm CG.
    Korean J Intern Med; 2014 May; 29(3):334-40. PubMed ID: 24851068
    [Abstract] [Full Text] [Related]

  • 27. Spot urine protein/creatinine ratio as a reliable estimate of 24-hour proteinuria in patients with immunoglobulin A nephropathy, but not membranous nephropathy.
    Kobayashi S, Amano H, Terawaki H, Ogura M, Kawaguchi Y, Yokoo T.
    BMC Nephrol; 2019 Aug 06; 20(1):306. PubMed ID: 31387546
    [Abstract] [Full Text] [Related]

  • 28. Additive antiproteinuric effect of converting enzyme inhibitor and losartan in normotensive patients with IgA nephropathy.
    Russo D, Pisani A, Balletta MM, De Nicola L, Savino FA, Andreucci M, Minutolo R.
    Am J Kidney Dis; 1999 May 06; 33(5):851-6. PubMed ID: 10213639
    [Abstract] [Full Text] [Related]

  • 29. Oral calcitriol for the treatment of persistent proteinuria in immunoglobulin A nephropathy: an uncontrolled trial.
    Szeto CC, Chow KM, Kwan BC, Chung KY, Leung CB, Li PK.
    Am J Kidney Dis; 2008 May 06; 51(5):724-31. PubMed ID: 18436082
    [Abstract] [Full Text] [Related]

  • 30. Safety of the combination of valsartan and benazepril in patients with chronic renal disease. European Group for the Investigation of Valsartan in Chronic Renal Disease.
    Ruilope LM, Aldigier JC, Ponticelli C, Oddou-Stock P, Botteri F, Mann JF.
    J Hypertens; 2000 Jan 06; 18(1):89-95. PubMed ID: 10678548
    [Abstract] [Full Text] [Related]

  • 31. Randomized controlled clinical trial of corticosteroids plus ACE-inhibitors with long-term follow-up in proteinuric IgA nephropathy.
    Manno C, Torres DD, Rossini M, Pesce F, Schena FP.
    Nephrol Dial Transplant; 2009 Dec 06; 24(12):3694-701. PubMed ID: 19628647
    [Abstract] [Full Text] [Related]

  • 32. Additive antiproteinuric effect of combination therapy with ACE inhibitor and angiotensin II receptor antagonist: differential short-term response between IgA nephropathy and diabetic nephropathy.
    Kim MJ, Song JH, Suh JH, Lee SW, Kim GA.
    Yonsei Med J; 2003 Jun 30; 44(3):463-72. PubMed ID: 12833584
    [Abstract] [Full Text] [Related]

  • 33. Coadministration of losartan and enalapril exerts additive antiproteinuric effect in IgA nephropathy.
    Russo D, Minutolo R, Pisani A, Esposito R, Signoriello G, Andreucci M, Balletta MM.
    Am J Kidney Dis; 2001 Jul 30; 38(1):18-25. PubMed ID: 11431176
    [Abstract] [Full Text] [Related]

  • 34. Treatment of IgA nephropathy.
    Pozzi C.
    J Nephrol; 2016 Feb 30; 29(1):21-5. PubMed ID: 26577268
    [Abstract] [Full Text] [Related]

  • 35. Tacrolimus decreases albuminuria in patients with IgA nephropathy and normal blood pressure: a double-blind randomized controlled trial of efficacy of tacrolimus on IgA nephropathy.
    Kim YC, Chin HJ, Koo HS, Kim S.
    PLoS One; 2013 Feb 30; 8(8):e71545. PubMed ID: 23977072
    [Abstract] [Full Text] [Related]

  • 36. Aldosterone breakthrough during aliskiren, valsartan, and combination (aliskiren + valsartan) therapy.
    Bomback AS, Rekhtman Y, Klemmer PJ, Canetta PA, Radhakrishnan J, Appel GB.
    J Am Soc Hypertens; 2012 Feb 30; 6(5):338-45. PubMed ID: 22995802
    [Abstract] [Full Text] [Related]

  • 37. Beneficial effects of olmesartan and temocapril on urinary liver-type fatty acid-binding protein levels in normotensive patients with immunoglobin A nephropathy.
    Nakamura T, Inoue T, Sugaya T, Kawagoe Y, Suzuki T, Ueda Y, Koide H, Node K.
    Am J Hypertens; 2007 Nov 30; 20(11):1195-201. PubMed ID: 17954367
    [Abstract] [Full Text] [Related]

  • 38. The effectiveness of steroid therapy for patients with advanced IgA nephropathy and impaired renal function.
    Moriyama T, Honda K, Nitta K, Yumura W, Nihei H.
    Clin Exp Nephrol; 2004 Sep 30; 8(3):237-42. PubMed ID: 15480901
    [Abstract] [Full Text] [Related]

  • 39. Combination therapy of prednisone and ACE inhibitor versus ACE-inhibitor therapy alone in patients with IgA nephropathy: a randomized controlled trial.
    Lv J, Zhang H, Chen Y, Li G, Jiang L, Singh AK, Wang H.
    Am J Kidney Dis; 2009 Jan 30; 53(1):26-32. PubMed ID: 18930568
    [Abstract] [Full Text] [Related]

  • 40. Proteinuria in the prognosis of IgA nephropathy.
    Aucella F, Netti GS, Piemontese M, Cincione IR, Infante B, Gesualdo L.
    Minerva Urol Nefrol; 2009 Sep 30; 61(3):235-48. PubMed ID: 19773725
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 11.